Special Thanks to the Scientific Advisory Board for Their Help in Developing this Program

Jeffrey T. Blue, M.S., Senior Manager, Vaccine Drug Product Development and New Technologies, Merck Research Laboratories

A. Krishna Prasad, Ph. D., Director, Vaccine Research & Early Development, Pfizer Inc.

Norman W. Baylor, Ph.D., President & Chief Executive Officer, Biologics Consulting Group, Inc.

Jonathan Liu, DVM, Ph.D., Director, Research and Development, Medimmune

David Volkin, Ph.D., Distinguished Professor, Pharmaceutical Chemistry, University of Kansas

Siva Sakhamuri, Ph.D., Director, Manufacturing, Sanofi Pasteur Biologics